Can hypercalcemia cause acute kidney injury?

Can Hypercalcemia Cause Acute Kidney Injury?

Yes, hypercalcemia directly causes acute kidney injury (AKI) through multiple mechanisms including polyuria leading to dehydration, decreased glomerular filtration rate, and direct nephrotoxic effects. 1

Mechanism of Kidney Injury

Hypercalcemia causes AKI through a well-established pathophysiologic cascade:

• Polyuria and dehydration: Excess calcium impairs renal concentrating ability, leading to progressive dehydration 1
• Direct reduction in GFR: Hypercalcemia decreases glomerular filtration rate through renal vasoconstriction 1, 2
• Increased calcium reabsorption: In conditions like adrenal insufficiency, enhanced tubular calcium reabsorption compounds the problem 2

Clinical Evidence

The relationship between hypercalcemia severity and AKI is dose-dependent:

• 56% of hypercalcemic patients develop AKI, with significantly higher calcium levels in those with AKI (median 12.85 mg/dL) versus those without (11.25 mg/dL; p=0.0039) 3
• 69.7% of patients with severe hypercalcemia (>14 mg/dL or 3.5 mmol/L) requiring hemodialysis developed AKI 4
• The severity of hypercalcemia directly correlates with kidney injury risk 3

Clinical Presentation by Severity

Mild hypercalcemia (<12 mg/dL): Polyuria and gastrointestinal disturbances begin 1

Moderate to severe (≥12 mg/dL): Progressive dehydration with declining GFR 1, 5

Severe (≥14 mg/dL or 3.5 mmol/L): Life-threatening emergency requiring immediate intervention, often with established AKI 5, 4

Management Algorithm

Immediate assessment (for calcium ≥3.5 mmol/L or 14 mg/dL):

1. Admit to hospital - conventional unit for stable patients, critical care for altered consciousness, severe dehydration with AKI, or significant comorbidities 5
2. Assess severity based on clinical manifestations, comorbidities, calcium level, and rapidity of onset 5

First-line treatment:

• Volume expansion with IV saline during first 24 hours, adapted to cardiac and renal function - this is the cornerstone of acute management 5
• Continue fluid resuscitation based on calcium trends 5

Definitive calcium-lowering therapy:

• IV bisphosphonates (zoledronic acid or pamidronate) after obtaining baseline labs, unless contraindicated (pregnancy) 1, 5
• Doses must be adjusted for renal function 5
• Denosumab as second-line in severely impaired renal function or when bisphosphonates fail/contraindicated 1, 5

Additional therapies:

• Steroids for calcitriol-mediated hypercalcemia 1
• Calcitonin for rapid onset of action (can combine with bisphosphonates) 6
• Calcimimetics for parathyroid carcinoma 6

Critical Pitfalls to Avoid

Do not delay treatment waiting for etiology workup in severe hypercalcemia - begin IV hydration and bisphosphonates immediately after drawing baseline labs 5

Recognize that CKD patients present with lower calcium levels than non-CKD patients (median 11.47 vs 13.01 mg/dL) yet still develop complications - don't be falsely reassured by "less elevated" values in chronic kidney disease 3

Adjust bisphosphonate dosing for renal function - failure to do so risks further nephrotoxicity 5

Consider non-standard etiologies: While malignancy and hyperparathyroidism dominate, medications (25% of cases), adrenal insufficiency, and sarcoidosis can cause hypercalcemia with AKI 2, 3

Prognosis

The relationship is bidirectional and potentially reversible:

• Prompt treatment can restore kidney function if intervention occurs before irreversible damage 7
• Prolonged or recurrent hypercalcemia leads to chronic kidney disease 7
• Mortality in severe hypercalcemia ranges from 14-52% depending on underlying etiology and pandemic-related diagnostic delays 4